BioCentury
ARTICLE | Finance

Analyst tracks

Biotech investor, banker and analyst personnel changes

June 23, 2014 7:00 AM UTC

David Martin joined Bloom Burton & Co. as a managing director and head of healthcare equity research. Martin was VP of corporate development and investor relations at fluorescent imaging company Novadaq Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ). Prior to that, Martin was a research analyst at Dundee Securities.

Swayampakula Ramakanth joined H.C. Wainwright & Co. LLC as a managing director and senior biotechnology analyst. Ramakanth was a healthcare equity analyst at Jefferies & Co...